We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Growth Noted in French Laboratory Market

By Labmedica staff writers
Posted on 13 Apr 2006
The Interprofessional Committee of Laboratory Suppliers (CIFL, Paris, France) has announced that the laboratory market in France increased by 2.6 % in the year 2005.

The CIFL is a professional association comprising 167 laboratory suppliers representing more than 80% of the laboratory market. More...
At the general assembly of the association, members were presented with a positive analysis of the laboratory market in France. The upturn was mainly noticeable in the fourth quarter, indicating a recovery of investment.
During the two previous years there had been a drop in activity, closely linked to relocation in the chemistry and pharmacy sectors, and to a freeze in public expenditures.

The results are supported by a recent market survey, conducted by CIFL together with Alcimed (Paris, France; www.alcimed.com), which forecasts a slight expansion in activity in 2006 and 2007. Alcimed is a strategy and marketing consulting firm specializing in biotechnologies, health, food, and cosmetics.

However, whereas biotechnologies recorded an overall increase of more than 6%, the analytical chemistry sector struggled to achieve a 1% growth. Some sectors remain sensitive in this market of around 1.3 million euros, particularly the largest ones such as pharmacy and chemistry, while the environment, cosmetics, and public laboratory sector show sustained vitality.

Within work groups or commissions, CIFL members deal with all topics that can influence the evolution of the laboratory profession. The main objective of CIFL is the promotion of the laboratory profession, and its greatest success in this area has been the Forum Labo (Paris, France) event.





Related Links:
CIFL
Alcimed

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.